Compare Synopsys, Inc. (SNPS) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Synopsys, Inc. vs Xylem, Inc. — how do they compare? Synopsys, Inc. trades at $509.81 (market cap $95.39B), while Xylem, Inc. trades at $103 (market cap $23.81B). The key difference: Synopsys, Inc. is far larger — about 4× Xylem, Inc.'s market cap, and Xylem, Inc. pays a 1.69% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Synopsys, Inc. for 71 Days and Xylem, Inc. for 50 Days on average.
| SNPS | XYL | |
|---|---|---|
Market Cap | $95.39B | $23.81B |
Volume | 3,374,903 | 2,234,713 |
Sector | Technology | Industrials |
52-Week High | $534.56 | $152.95 |
52-Week Low | $367.70 | $100.92 |
Typical Hold Time | 71 Days | 50 Days |
Enterprise Value | $102.62B | $25.59B |
Dividend Yield | — | 1.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Synopsys (SNPS) trades at $509.99, up 1.46% today, and is near its 52-week high. The stock exhibits a bullish technical trend with strong moving average support. Recent quarterly earnings have consistently beaten estimates, and the company's Investor Day in October 2026 highlighted transformative AI partnerships with OpenAI and Amazon, driving a 13% stock surge and upward revisions to long-term revenue guidance.
The outlook is positive, supported by robust analyst sentiment (93% buy ratings) and a consensus price target of $572.54. Key opportunities include AI-driven growth in chip design software and margin expansion from the Ansys acquisition. Risks involve high valuation multiples and integration execution challenges.
XYL trades at $102.71, up 0.86% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $9.04B in 2025 with a net income margin of 10.59%, and has beaten EPS estimates in recent quarters. Recent developments include a $1.5B senior note offering to fund acquisitions of Cornell Pump and Roper Pump, and the appointment of a new CFO.
Outlook is supported by strong water-solutions demand and margin expansion, but risks include China weakness and higher debt. Analysts are mixed with a consensus price target of $149.13, implying significant upside from current levels, though near-term technical pressure may persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
